Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Historic Tax Provisions for Arcus Biosciences (RCUS) over the last 4 years, with Q4 2024 value amounting to $1.0 million.

  • Arcus Biosciences' Tax Provisions changed 0.0% to $1.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 8333.33% down from last year.
  • Latest data reveals that Arcus Biosciences reported Tax Provisions of $1.0 million as of Q4 2024, which was down 0.0% from $1.0 million recorded in Q4 2023.
  • Arcus Biosciences' 5-year Tax Provisions high stood at $2.0 million for Q4 2021, and its period low was $1.0 million during Q1 2022.
  • Its 4-year average for Tax Provisions is $1.4 million, with a median of $1.0 million in 2022.
  • In the last 5 years, Arcus Biosciences' Tax Provisions surged by 10000.0% in 2023 and then changed by 0.0% in 2024.
  • Arcus Biosciences' Tax Provisions (Quarter) stood at $2.0 million in 2021, then tumbled by 50.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
  • Its last three reported values are $1.0 million in Q4 2024, $1.0 million for Q4 2023, and $2.0 million during Q3 2023.